NIF
NIFTY MIDSML HLTH
NSE
Active
LTP
51,926.15
+211.40
(+0.41%)
Prev Close: 51,714.75 • 29-Sep-2026 15:30
Open
51,839.40
Prev
51,714.75
High
52,268.40
Low
51,654.35
Valuation
P/E
44.9
P/B
5.4
Div Yield
0.30%
Volume
331
52W L: 40,353
52W H: 53,415
Historical Returns
1W
-1.73%
1M
-1.51%
3M
+5.01%
6M
+23.00%
1Y
+20.21%
2Y
+22.56%
3Y
+0.00%
5Y
+0.00%
Returns at a glance
1W
-1.73%
1M
-1.51%
3M
+5.01%
6M
+23.00%
1Y
+20.21%
2Y
+22.56%
3Y
+0.00%
5Y
+0.00%
Summary
Constituents
30
Total Weight
99.99%
Sectors
1
Review
6 mo.
Market Movers
Live
Top Gainers
% Change
1
GLENMARK
₹2,441.50
+4.98%
₹115.80 change
2
MANKIND
₹2,545.00
+4.49%
₹109.40 change
3
ACUTAAS
₹3,317.90
+3.22%
₹103.50 change
4
GLAND
₹2,985.00
+3.07%
₹89.00 change
5
ABBOTINDIA
₹27,310.00
+2.13%
₹570.00 change
Top Losers
% Change
1
GLAXO
₹2,777.30
-4.11%
₹-119.10 change
2
SYNGENE
₹365.90
-2.69%
₹-10.10 change
3
NH
₹1,773.00
-2.59%
₹-47.10 change
4
PFIZER
₹3,900.00
-1.71%
₹-68.00 change
5
ASTERDM
₹735.45
-1.59%
₹-11.90 change
Index Announcements
6 updates
FOR
FORTIS
Fortis Healthcare Limited
General Updates
Fortis Healthcare Limited has informed the Exchange about General Updates on Announcement / Press release filed by IHH Healthcare Berhad ( IHH )
GLA
GLAND
Gland Pharma Limited
Copy of Newspaper Publication
Gland Pharma Limited has informed the Exchange about Copy of Newspaper Publication
PFI
PFIZER
Pfizer Limited
Action(s) initiated or orders passed
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has, on September 28, 2026, received an...
MED
MEDANTA
Global Health Limited
Press Release
Global Health Limited has informed the Exchange regarding a press release dated September 29, 2026, titled "Medanta to expand Healthcare Footprint in Uttar Pradesh with the Acquisi...
PPL
PPLPHARMA
Piramal Pharma Limited
Trading Window
Piramal Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
PPL
PPLPHARMA
Piramal Pharma Limited
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Disclosure under Regulation 30 of Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015
Constituents (30)
| # | Symbol | Company | Sector | LTP | Change | Change % | Weight | Free Float |
|---|---|---|---|---|---|---|---|---|
| 26 | SYNGENE | — | 365.90 | -10.10 | -2.69% |
1.38%
|
— | |
| 27 | NATCOPHARM | — | 842.60 | +14.05 | +1.70% |
1.31%
|
— | |
| 28 | PFIZER | — | 3,900.00 | -68.00 | -1.71% |
1.14%
|
— | |
| 29 | COHANCE | — | 455.10 | +1.80 | +0.40% |
1.12%
|
— | |
| 30 | POLYMED | — | 1,629.10 | -7.60 | -0.46% |
1.00%
|
— |
Sector Weightage
1
sectors
Other100%
Index Info
CodeNIFTYMIDSMLHLTH
CategorySectoral
ExchangeNSE
Base Value1,000.00
Base Date01 Jan 2000
F&O TradableNo
Top 5 by Weight
1
SYNGENE
1.38%
2
NATCOPHARM
1.31%
3
PFIZER
1.14%
4
COHANCE
1.12%
5
POLYMED
1.00%